Re: Farmas USA
Articulo negativo AMRN.
http://seekingalpha.com/article/1181101-amarin-s-tough-road-ahead?source=email_rt_article_readmore
con esta frase suya lo dice todo : "I believe AMRN is a strong sell here"
a 8 medios ... strong sell ... la madre que lo pario
y esta es otra perla, es sobre REDUCE-IT:
"While I admit this is a far more meaningful and potentially lucrative indication for AMRN, the trial began barely over a year ago and is expected to last 6 years. At this rate, AMRN could be broke and bankrupt by then so investing now for a trial alone 5 years away from completion is probably not a sound investing strategy"
como no, tuvo que soltar la palabrita "bancarrota", si nola deja caer revienta ...